Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66715-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- GSTP1 antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated GSTP1 antibody (Cat. #66715-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2D4A6
- Vial size
- 20ul, 150ul
Submitted references N6022 attenuates cerebral ischemia/reperfusion injury-induced microglia ferroptosis by promoting Nrf2 nuclear translocation and inhibiting the GSNOR/GSTP1 axis.
Targeted reversal of multidrug resistance in ovarian cancer cells using exosome‑encapsulated tetramethylpyrazine.
Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma.
NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway.
Ginsenoside Rg1 protects cardiac mitochondrial function via targeting GSTP1 to block S-glutathionylation of optic atrophy 1.
Sesquiterpene lactones from Elephantopus scaber exhibit cytotoxic effects on glioma cells by targeting GSTP1.
Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1.
Duan WL, Ma YP, Wang XJ, Ma CS, Han B, Sheng ZM, Dong H, Zhang LY, Li PA, Zhang BG, He MT
European journal of pharmacology 2024 Jun 5;972:176553
European journal of pharmacology 2024 Jun 5;972:176553
Targeted reversal of multidrug resistance in ovarian cancer cells using exosome‑encapsulated tetramethylpyrazine.
Zhao C, Qiu L, Wu D, Zhang M, Xia W, Lv H, Cheng L
Molecular medicine reports 2024 Feb;29(2)
Molecular medicine reports 2024 Feb;29(2)
Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma.
Chen R, Lo HH, Yang C, Law BYK, Chen X, Lam CCI, Ho C, Cheong HL, Li Q, Zhong C, Ng JPL, Peter CKF, Wong VKW
Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 Feb;124:155310
Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 Feb;124:155310
NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway.
Yin S, Zhao S, Li J, Liu K, Ma X, Zhang Z, Wang R, Tian J, Liu F, Song Y, Song M, Zhao R, Yang R, Lee MH, Dong Z
Cellular and molecular life sciences : CMLS 2023 Jul 18;80(8):211
Cellular and molecular life sciences : CMLS 2023 Jul 18;80(8):211
Ginsenoside Rg1 protects cardiac mitochondrial function via targeting GSTP1 to block S-glutathionylation of optic atrophy 1.
Zhu H, Yan C, Yao P, Li P, Li Y, Yang H
Free radical biology & medicine 2023 Aug 1;204:54-67
Free radical biology & medicine 2023 Aug 1;204:54-67
Sesquiterpene lactones from Elephantopus scaber exhibit cytotoxic effects on glioma cells by targeting GSTP1.
Yan QL, Wang XY, Bai M, Zhang X, Song SJ, Yao GD
Bioorganic chemistry 2022 Dec;129:106183
Bioorganic chemistry 2022 Dec;129:106183
Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1.
Feng Q, Li X, Sun W, Sun M, Li Z, Sheng H, Xie F, Zhang S, Shan C
Biochemical pharmacology 2020 Aug;178:114092
Biochemical pharmacology 2020 Aug;178:114092
No comments: Submit comment
No validations: Submit validation data